Oramed Pharmaceuticals (ORMP) EPS (Basic) (2011 - 2026)
Oramed Pharmaceuticals' (ORMP) quarterly EPS (Basic) came in at $0.94 in Q1 2026, up 606.9% YoY from $0.13 in Q1 2025, and up 83.54% on a QoQ basis from $0.51 in Q4 2025.
Oramed Pharmaceuticals (ORMP) EPS (Basic) (2011 - 2026) Analysis & Trends
Oramed Pharmaceuticals (ORMP) has 15 years of EPS (Basic) data on file, last reported at $0.94 in Q1 2026.
- Quarterly EPS (Basic) rose 606.9% year-over-year to $0.94 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.97 (up 533.2% YoY) and the FY2025 annual result came in at $1.82, up 488.2% from the prior year.
- EPS (Basic) grew to $0.94 in Q1 2026, from $0.51 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $1.16 in Q3 2025 to a low of -$0.48 in Q3 2024.
- A 5-year average of $0.08 and a median of -$0.08 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) soared 788.43% — and 2025, when it sank 593.43%.
- Tracing ORMP's EPS (Basic) over 5 years: stood at -$0.3 in 2022, then jumped by 210.23% to $0.33 in 2023, then slumped by 175.74% to -$0.25 in 2024, then soared by 304.93% to $0.51 in 2025, then surged by 83.54% to $0.94 in 2026.
- The last three EPS (Basic) figures came in at $0.94 (Q1 2026), $0.51 (Q4 2025), and $1.16 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Oramed Pharmaceuticals | 197.61 Mn | 197.61 Mn | - | 1.90 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.84 |
| Mar 31, 2026 | 0.94 |
| Dec 31, 2025 | 0.51 |
| Sep 30, 2025 | 1.16 |
| Jun 30, 2025 | 0.32 |
| Mar 31, 2025 | -0.19 |
| Dec 31, 2024 | -0.25 |
| Sep 30, 2024 | -0.48 |
| Jun 30, 2024 | 0.22 |
| Mar 31, 2024 | 0.04 |
| Dec 31, 2023 | 0.33 |
| Sep 30, 2023 | -0.08 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | -0.08 |
| Dec 31, 2022 | -0.30 |
| Sep 30, 2022 | -0.18 |
| Jun 30, 2022 | -0.27 |
| Mar 31, 2022 | -0.27 |
| Aug 31, 2021 | -0.78 |
| Nov 30, 2019 | -0.14 |